423 related articles for article (PubMed ID: 11074608)
41. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
Kim TK; Mo EK; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
Lung Cancer; 2001; 31(2-3):181-91. PubMed ID: 11165397
[TBL] [Abstract][Full Text] [Related]
42. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
43. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D
Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588
[TBL] [Abstract][Full Text] [Related]
44. Expression of transforming growth factor-beta receptors during hyperoxia-induced lung injury and repair.
Zhao Y; Gilmore BJ; Young SL
Am J Physiol; 1997 Aug; 273(2 Pt 1):L355-62. PubMed ID: 9277447
[TBL] [Abstract][Full Text] [Related]
45. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
46. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
Gold LI; Sung JJ; Siebert JW; Longaker MT
Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
[TBL] [Abstract][Full Text] [Related]
47. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
[TBL] [Abstract][Full Text] [Related]
48. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
[TBL] [Abstract][Full Text] [Related]
49. Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine.
Tsujiuchi T; Sasaki Y; Tsutsumi M; Konishi Y
Jpn J Cancer Res; 2000 Nov; 91(11):1090-5. PubMed ID: 11092971
[TBL] [Abstract][Full Text] [Related]
50. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB
Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114
[TBL] [Abstract][Full Text] [Related]
51. Irradiated homozygous TGF-beta1 knockout fibroblasts show enhanced clonogenic survival as compared with TGF-beta1 wild-type fibroblasts.
Von Pfeil A; Hakenjos L; Herskind C; Dittmann K; Weller M; Rodemann HP
Int J Radiat Biol; 2002 May; 78(5):331-9. PubMed ID: 12020424
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development.
Sturlan S; Oberhuber G; Beinhauer BG; Tichy B; Kappel S; Wang J; Rogy MA
Carcinogenesis; 2001 Apr; 22(4):665-71. PubMed ID: 11285204
[TBL] [Abstract][Full Text] [Related]
53. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
54. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone.
Horner A; Kemp P; Summers C; Bord S; Bishop NJ; Kelsall AW; Coleman N; Compston JE
Bone; 1998 Aug; 23(2):95-102. PubMed ID: 9701467
[TBL] [Abstract][Full Text] [Related]
55. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
[TBL] [Abstract][Full Text] [Related]
56. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor.
Jung CW; Kim ES; Seol JG; Park WH; Lee SJ; Kim BK; Lee YY
Leuk Res; 1999 Dec; 23(12):1105-12. PubMed ID: 10613355
[TBL] [Abstract][Full Text] [Related]
57. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.
Bonecini-Almeida MG; Ho JL; Boéchat N; Huard RC; Chitale S; Doo H; Geng J; Rego L; Lazzarini LC; Kritski AL; Johnson WD; McCaffrey TA; Silva JR
Infect Immun; 2004 May; 72(5):2628-34. PubMed ID: 15102771
[TBL] [Abstract][Full Text] [Related]
58. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
Wong YC; Xie W; Tsao SW
Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
[TBL] [Abstract][Full Text] [Related]
59. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
60. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
Carethers JM; Pham TT
In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
